The Board granted a rating of 60 percent for the Veteran's residuals of prostate cancer, effective July 1, 2020.
The deciding factor: The Veteran reported needing to change his absorbent material more than four times a day, which met the criteria for a 60 percent rating under Diagnostic Code 7528.
- Claimed conditions
- Residuals of prostate cancer
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- October 3, 2024
- Citation
- A24063177
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the claims for a rating reduction and increased rating for prostate cancer, as well as the TDIU claim, due to the need for additional development of evidence.
- Denied
The Board denied an earlier effective date for service connection of residuals of prostate cancer, finding that the August 10, 2022 effective date is appropriate under the PACT Act.
- Denied
The Board denied the appeals for increased ratings and TDIU, as the evidence did not support higher ratings or unemployability due to service-connected disabilities.
- Granted
The Veteran was granted special monthly compensation (SMC) based on the need for aid and attendance due to a service-connected prostate disability.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.